BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 26676847)

  • 1. Eczema Trials: Quality of Life Instruments Used and Their Relation to Patient-reported Outcomes. A Systematic Review.
    Heinl D; Chalmers J; Nankervis H; Apfelbacher CJ
    Acta Derm Venereol; 2016 Jun; 96(5):596-601. PubMed ID: 26676847
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recommended core outcome instruments for health-related quality of life, long-term control and itch intensity in atopic eczema trials: results of the HOME VII consensus meeting.
    Thomas KS; Apfelbacher CA; Chalmers JR; Simpson E; Spuls PI; Gerbens LAA; Williams HC; Schmitt J; Gabes M; Howells L; Stuart BL; Grinich E; Pawlitschek T; Burton T; Howie L; Gadkari A; Eckert L; Ebata T; Boers M; Saeki H; Nakahara T; Katoh N
    Br J Dermatol; 2021 Jul; 185(1):139-146. PubMed ID: 33393074
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quality of life in Swedish children with eczema.
    Gånemo A; Svensson A; Lindberg M; Wahlgren CF
    Acta Derm Venereol; 2007; 87(4):345-9. PubMed ID: 17598039
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A randomized controlled trial in children with eczema: nurse practitioner vs. dermatologist.
    Schuttelaar ML; Vermeulen KM; Drukker N; Coenraads PJ
    Br J Dermatol; 2010 Jan; 162(1):162-70. PubMed ID: 19849695
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An audit of the impact of a consultation with a paediatric dermatology team on quality of life in infants with atopic eczema and their families: further validation of the Infants' Dermatitis Quality of Life Index and Dermatitis Family Impact score.
    Beattie PE; Lewis-Jones MS
    Br J Dermatol; 2006 Dec; 155(6):1249-55. PubMed ID: 17107397
    [TBL] [Abstract][Full Text] [Related]  

  • 6. IDQoL, CDLQI and the 45-item CADIS received a sufficient content validity rating during the HOME VII meeting in Japan: a group discussion study.
    Gabes M; Apfelbacher C;
    J Eur Acad Dermatol Venereol; 2021 Feb; 35(2):458-463. PubMed ID: 32745352
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Which outcomes have been measured in hand eczema trials? A systematic review.
    Rönsch H; Apfelbacher C; Brans R; Matterne U; Molin S; Ofenloch R; Oosterhaven JAF; Schuttelaar MLA; Weisshaar E; Yew YW; Bauer A
    Contact Dermatitis; 2019 Apr; 80(4):201-207. PubMed ID: 30632613
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recommended core outcome instruments for health-related quality of life, long-term control and itch intensity in atopic eczema trials: results of the HOME VII consensus meeting.
    Thomas KS; Apfelbacher CA; Chalmers JR; Simpson E; Spuls PI; Gerbens LAA; Williams HC; Schmitt J; Gabes M; Howells L; Stuart BL; Grinich E; Pawlitschek T; Burton T; Howie L; Gadkari A; Eckert L; Ebata T; Boers M; Saeki H; Nakahara T; Katoh N
    Br J Dermatol; 2020 Nov; ():. PubMed ID: 33179283
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dermatology Quality of Life Index scores in Bangladeshi patients with atopic eczema and their families in East London.
    Tawfik SS; Thomas BR; Kelsell DP; Grigg J; O'Toole EA
    Br J Dermatol; 2023 Mar; 188(4):524-532. PubMed ID: 36745558
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Randomized Controlled Trial of an Eczema Care Plan.
    Rea CJ; Tran KD; Jorina M; Wenren LM; Hawryluk EB; Toomey SL
    Acad Pediatr; 2018; 18(7):789-796. PubMed ID: 29505898
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hand eczema and health-related quality of life; a comparison of EQ-5D and the Dermatology Life Quality Index (DLQI) in relation to the Hand Eczema Extent Score (HEES).
    Lindberg M; Bingefors K; Meding B; Berg M
    Contact Dermatitis; 2013 Sep; 69(3):138-43. PubMed ID: 23948032
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Measurement properties of quality-of-life measurement instruments for infants, children and adolescents with eczema: a systematic review.
    Heinl D; Prinsen CAC; Sach T; Drucker AM; Ofenloch R; Flohr C; Apfelbacher C
    Br J Dermatol; 2017 Apr; 176(4):878-889. PubMed ID: 27543747
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Health outcome measures in atopic dermatitis: a systematic review of trends in disease severity and quality-of-life instruments 1985-2010.
    Rehal B; Armstrong AW
    PLoS One; 2011 Apr; 6(4):e17520. PubMed ID: 21533286
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Correlations among steroid fear, acceptability, usage frequency, quality of life and disease severity in childhood eczema.
    Hon KL; Tsang YC; Pong NH; Luk DC; Lee VW; Woo WM; Lam CY; Yeung YT; Chau YS; Chui KK; Li KH; Leung TF
    J Dermatolog Treat; 2015 Oct; 26(5):418-25. PubMed ID: 25895012
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of the Dermatology Life Quality Index and the Children's Dermatology Life Quality Index in assessment of quality of life in patients with psoriasis aged 16-17 years.
    van Geel MJ; Maatkamp M; Oostveen AM; de Jong EM; Finlay AY; van de Kerkhof PC; Seyger MM
    Br J Dermatol; 2016 Jan; 174(1):152-7. PubMed ID: 26361284
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A service evaluation of the Eczema Education Programme: an analysis of child, parent and service impact outcomes.
    Ersser SJ; Farasat H; Jackson K; Dennis H; Sheppard ZA; More A
    Br J Dermatol; 2013 Sep; 169(3):629-36. PubMed ID: 23646904
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Overview of studies of treatments for hand eczema-the EDEN hand eczema survey.
    Van Coevorden AM; Coenraads PJ; Svensson A; Bavinck JN; Diepgen TL; Naldi L; Elsner P; Williams HC;
    Br J Dermatol; 2004 Aug; 151(2):446-51. PubMed ID: 15327553
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Health-related quality of life and hand eczema--a comparison of two instruments, including factor analysis.
    Wallenhammar LM; Nyfjäll M; Lindberg M; Meding B
    J Invest Dermatol; 2004 Jun; 122(6):1381-9. PubMed ID: 15175027
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Measurement properties of patient-reported outcome measures for eczema control: a systematic review.
    Stuart BL; Howells L; Pattinson RL; Chalmers JR; Grindlay D; Rogers NK; Grinich E; Pawlitschek T; Simpson EL; Thomas KS
    J Eur Acad Dermatol Venereol; 2021 Oct; 35(10):1987-1993. PubMed ID: 33977561
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Health-related Quality of Life in Children with Moderate to Severe Atopic Dermatitis.
    Ražnatović Djurović M; Janković J; Tomić Spirić V; Janković S
    Acta Dermatovenerol Croat; 2015; 23(3):178-84. PubMed ID: 26476901
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.